参考文献/References:
[1] 刘 冲,唐 浩,邓 霖,等.血清miRNA-186,miRNA-30 c在肝细胞性癌中诊断价值的研究[J].现代检验医学杂志,2016,31(6):44-47.
Liu C,Tang H,Deng L,et al.Research of diagnostic application ofserum miRNA-186 and miRNA-30c in patients with hepatocellular carcinoma[J].Journal of Modern Laboratory Medicine,2016,31(6):44-47.
[2] 任雪维,张吉才.miR-29在肿瘤中的研究进展[J].中国肿瘤临床,2016,43(17):775-779.
Ren XW,Zhang JC.Research progress of microRNA-29 in tumors[J].Chinese Journal of Clinical Oncology,2016,43(17):775-779.
[3] Parpart S,Roessler S,Dong F,et al.Modulation of miR-29 expression byalpha-fetoprotein is linked to the hepatocellular carcinoma epigenome[J].Hepatology,2014,60(3):872-883.
[4] Xing TJ,Jiang DF,Huang JX,et al.Expression and clinical significanceof miR-122 and miR-29 in hepatitis B virus-related liver disease[J].GenetMol Res,2014,13(3):7912-7918.
[5] Schmittgen TD,Jiang J,Liu Q,et al.A high-throughput method to monitor the expression of microRNA precursors[J].Nucleic Acids Res,2004,32(4):e43.
[6] 李步任,张惠冰,张诗颜.ROC曲线及Logistic回归评价血清AFU,AFP和TK1在原发性肝癌的诊断价值[J].现代检验医学杂志,2015,30(6):56-59.
Li BR,Zhang HB,Zhang SY.Diagnostic value of serum AFU,AFP and TK1 for primary liver cancer with logistic regression and ROC curve[J].Journalof Modern Laboratory Medicine,2015,30(6):56-59.
[7] Zhou J,Yu L,Gao X,et al.Plasma microRNA panel to diagnose hepatitis Bvirus-related hepatocellular carcinoma[J].J Clin Oncol,2011,29(36):4781-4788.
[8] Zhu HT,Hasan AM,Liu RB,et al.Serum microRNA profiles as prognostic biomarkers for HBV-positive hepatocellular carcinoma[J].Oncotarget,2016,7(29):45637-45648.
[9] Li LM,Hu ZB,Zhou ZX,et al.Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma[J].Cancer Res,2010,70(23):9798-9807.
[10] Fabbri M,Garzon R,Cimmino A,et al.MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and3B[J].Proc Natl Acad Sci USA,2007,104(40):15805-15810.
[11] Lee TY,Ezelle HJ,Venkataraman T,et al.Regulation of human RNase-L by the miR-29 family reveals a novel oncogenic role in chronic myelogenous leukemia[J].J Interferon Cytokine Res,2013,33(1):34-42.
[12] Rothschild SI,Tschan MP,Federzoni EA,et al.MicroRNA-29b is involvedin the Src-ID1 signaling pathway and is dysregulated in human lung adenocarcinoma[J].Oncogene,2012,31(38):4221-4232.
[13] Cochrane DR,Jacobsen BM,Connaghan KD,et al.Progestin regulated miRNAs that mediate progesterone receptor action in breast cancer[J].Mol Cell Endocrinol,2012,355(1):15-24.
[14] Roderburg C,Urban GW,Bettermann K,et al.Micro-RNA profiling revealsa role for miR-29 in human and murine liver fibrosis[J].Hepatology, 2011,53(1):209-218.
[15] Brain O,Owens BM,Pichulik T,et al.The intracellular sensor NOD2 induces microRNA-29 expression in human dendritic cells to limit IL-23 release[J].Immunity,2013,39(3):521-536.
[16] Huang C,Zheng JM,Cheng Q,et al.Serum microRNA-29 levels correlate with disease progression in patients with chronic hepatitis B virus infection[J].J Dig Dis,2014,15(11):614-621.
[17] Xiong Y,Fang JH,Yun JP,et al.Effects of microRNA-29 on apoptosis,tumorigenicity,and prognosis of hepatocellular carcinoma[J].Hepatology,2010,51(3):836-845.